Back to YC Companies

    FinalDose

    Spring 2026
    Active

    Programmable DNA drug destroying all cancers, unlocking 80% of targets

    5 people View on YC

    FinalDose at a glance

    Y Combinator batch
    Spring 2026
    Status
    Active
    Industry
    Healthcare
    Team size
    5 people
    Location
    Not recorded
    Website
    Not recorded

    Every field above comes from the Y Combinator company record. Nothing is estimated.

    Compare FinalDose with similar YC companies →

    About FinalDose

    FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.

    Tags:
    Gene Therapy
    Therapeutics
    Genetic Engineering
    AI